|
|
P3 Health Partners Inc (NASDAQ: PIII) |
|
Price: $0.1749
$0.01 
3.064%
|
| Day's High:
| $0.1772
| Week Perf:
| -4.22 %
|
| Day's Low: |
$ 0.17 |
30 Day Perf: |
-13.84 % |
| Volume (M): |
112 |
52 Wk High: |
$ 1.12 |
| Volume (M$): |
$ 20 |
52 Wk Avg: |
$0.44 |
| Open: |
$0.17 |
52 Wk Low: |
$0.16 |
|
|
| Market Capitalization (Millions $) |
29 |
| Shares
Outstanding (Millions) |
165 |
| Employees |
2,278 |
| Revenues (TTM) (Millions $) |
1,477 |
| Net Income (TTM) (Millions $) |
-250 |
| Cash Flow (TTM) (Millions $) |
11 |
| Capital Exp. (TTM) (Millions $) |
0 |
P3 Health Partners Inc
P3 Health Partners Inc is a healthcare management organization based in Nevada, founded by Dr. Amir Bacchus and his team in 2015, with an aim to transform how healthcare is delivered to seniors, who are one of the most vulnerable segments of society. The company has been successful in creating an innovative model for healthcare with its core focus on proactive, preventive, and personalized healthcare delivery.
P3 Health Partners Inc was established with the belief that traditional healthcare delivery models were not addressing the unique needs of seniors. The organization recognized the need to revolutionize the traditional system and develop an approach that is patient-centered, data-driven, and outcome-based. This approach is designed to ensure that patients receive the care they need when they need it most.
The company's underlying philosophy is centered on prevention, proactivity, and personalized care for seniors. It aims to provide value-based care to its patients while ensuring optimal health outcomes. P3 Health Partners Inc's innovative model integrates primary care, specialty care, behavioral health, and other ancillary services under one roof.
The organization provides comprehensive care coordination to its patients, which includes regular check-ups, preventive health screenings, disease management, and personalized care plans. The care model is enhanced by a strong focus on education and behavioral health support, which helps patients take ownership of their health and make informed decisions.
P3 Health Partners Inc is committed to ensuring that healthcare is accessible to all senior patients, regardless of their financial status. The company participates in Medicare programs and accepts several health insurance plans to ensure that it can provide affordable care to its patients.
To support its patient-centered model, P3 Health Partners Inc has developed an advanced data analytics platform that allows healthcare providers to monitor patient outcomes and identify areas for improvement. This data is used to inform care planning and decision-making, ensuring that patients receive the best possible care.
Overall, P3 Health Partners Inc is a unique healthcare management organization that is dedicated to improving the health outcomes of senior patients. Its innovative model, patient-centered care, and advanced data analytics platform position the organization to continue to thrive in the rapidly changing landscape of the healthcare industry.
Company Address: 2370 Corporate Circle Suite 300 Henderson 89074 NV
Company Phone Number: 910-3950(Registrant?s telephone number, including area code) Stock Exchange / Ticker: NASDAQ PIII
|
|
|
|
|
|
|
| Stock Performances by Major Competitors |
|
|
|
| Business Update
Published Tue, Jul 9 2024 2:54 PM UTC
In the latest strides towards revolutionizing healthcare delivery, P3 Health Partners Inc. (NASDAQ: PIII) has recently announced a strategic partnership with Innovaccer Inc., a leading healthcare AI company. This collaboration marks a significant milestone in P3 Health Partners ongoing journey to advance value-based care initiatives, focusing on improved patient outcomes, c...
|
| Business Update
Published Fri, May 10 2024 12:47 AM UTC
In an intriguing turn of events, P3 Health Partners Inc., popularly known as P3 or the Company (NASDAQ: PIII), has emerged into the spotlight after announcing a crucial dictum made by its Board of Directors (the Board), including independent members. The company s board has agreed to gift employment inducement equity grants to their new CEO and President, Aric Coffman, M.D. ...
|
| P3 Health Partners Inc
P3 Health Partners Inc., a leading population health management company, recently announced its financial results for the first quarter of 2024. The company reported a significant surge in revenue, recording a 28.606% increase to $388.49 million compared to the same period last year. Although they experienced a loss of $-0.16 per share, the revenue growth outperformed the Medical Equipment & Supplies industry average of 6.51% during the same period.
The positive financial results showcase P3 Health Partners Inc.'s impressive momentum in the healthcare sector. The company's strategic focus on improving consumer economics, organizational excellence, and operational efficiency has contributed to its success. Despite the shortfall in profitability, P3 Health Partners Inc. has managed to increase its revenue by 12.001% from $346.86 million in the previous reporting season.
|
| Business Update
Published Thu, May 9 2024 11:47 PM UTC
Henderson-based healthcare company P3 Health Partners Inc. (P3) has recently announced the approval of employment inducement equity grants to Dr. Aric Coffman, who will assume the position of Chief Executive Officer and President. The grants, totaling 12,100,000 shares, were approved by the company s Board of Directors, including independent members, in accordance with Nasda...
|
| P3 Health Partners Inc
P3 Health Partners Inc. is a patient-centered and physician-led population health management company that has shown significant improvement in its financial performance in the fiscal fourth quarter of 2023. The company reported a decrease in loss per share from $-1.88 to $-0.03 compared to the previous year, and an improvement in EPS from $-0.12 to $-0.03 from the previous reporting period.
One of the most notable achievements for P3 Health Partners Inc. in the fiscal fourth quarter of 2023 was the significant increase in revenue. The company reported a revenue of $346.86 million, a jump of 34.332% from $258.21 million in the same reporting period a year prior. Sequentially, revenue also improved by 20.291% from $288.35 million. This strong revenue growth not only exceeded the company's own expectations but also outperformed industry peers in the Medical Equipment & Supplies sector, who only saw a 6.74% revenue growth in the same period.
In terms of profitability, P3 Health Partners Inc. reported a net loss of $-69.107 million in the fiscal fourth quarter of 2023, a significant improvement from the net deficit of $-532.332 million in the same reporting period a year ago. The company also noted a net deficit of $-186.43 million for the fiscal period 2023, with a total revenue of $1.27 billion. This improvement in profitability is a testament to the company's focus on driving operational efficiencies and improving financial performance.
|
| Per Share |
Current |
| Earnings (TTM) |
-0.65 $ |
| Revenues (TTM) |
8.97 $
|
| Cash Flow (TTM) |
0.06 $ |
| Cash |
0.38 $
|
| Book Value |
0.73 $
|
| Dividend (TTM) |
0 $ |
|
|
| Per Share |
|
| Earnings (TTM) |
-0.65 $
|
| Revenues (TTM) |
8.97 $ |
| Cash Flow (TTM) |
0.06 $ |
| Cash |
0.38 $
|
| Book Value |
0.73 $ |
| Dividend (TTM) |
0 $ |
|
|
| |
| Capitated Revenue |
|
 98.78 % |
of total Revenue |
| Health Care Other |
|
1.22 % |
of total Revenue |
| Health Care Clinical Fees Insurance Revenue |
|
0.42 % |
of total Revenue |
| Health Care Coordination Management Fees |
|
0.76 % |
of total Revenue |
| Health Care Incentive Fees |
|
0.03 % |
of total Revenue |
| |
On March 28 2024 the P3 Health Partners Inc provided following guidance
are pleased with our performance and remain committed to our mission of improving healthcare outcomes for our patients.
Looking ahead to 2024, we expect continued growth and success as we continue to focus on providing high-quality care to our patients. We estimate that our revenue will increase to approximately $1.5 billion, representing a 15% growth from 2023. We also anticipate that our adjusted EBITDA margins will be in the range of 8-10%.
Additionally, we are excited to continue expanding our network of providers and enhancing our capabilities to deliver value-based care. We remain confident in our ability to drive positive outcomes for both our patients and shareholders.
In conclu...
|
|
|
5.58%